ORPHAZYME A/S |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,047 DKK | -4.80% |
|
-4.82% | -21.28% |
| Mar. 27 | Orphazyme A/S Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 04 | FDA Extends Review of Zevra's Arimoclomol by Three Months | DJ |
Chart calendar Orphazyme A/S
594bf7a750c055e1633a.80vhe67V8_6JJw4zTx38GLVJm21h66b0SNPWKUF-Xrc.v36FCNuXwY3TbklkIUmuK-on4QYKrJ-lGoeHSwk2BM3BCtFL173Fyv9eTw~3c686b5568577658cbd9f7555e58c1c3
Upcoming events on Orphazyme A/S
Past events on Orphazyme A/S
| 2023-09-11 | Q2 2023 Earnings Release |
| 2023-05-17 05:00 am | Annual General Meeting |
| 2023-04-25 04:20 pm | Q4 2022 Earnings Release |
| 2022-09-19 | Interim 2022 Earnings Release |
| 2022-06-29 08:00 am | Annual General Meeting |
| 2022-06-07 05:34 pm | FY 2021 Earnings Release |
| 2022-05-30 07:00 am | Shareholders Meeting |
| 2022-04-07 05:00 am | Shareholders Meeting |
| 2022-02-15 11:00 am | Extraordinary Shareholders Meeting |
| 2022-02-09 | WORLD Symposium - Poster 236 |
| 2022-02-08 | WORLD Symposium - Poster 229 |
| 2021-08-31 08:00 am | Interim 2021 Earnings Call |
| 2021-08-31 01:00 am | Interim 2021 Earnings Release |
| 2021-06-18 08:00 am | Niemann-Pick Disease Type C (NPC) FDA Approval Update Call - Second Call |
| 2021-06-18 02:00 am | Niemann-Pick Disease Type C (NPC) FDA Approval Update Call - First Call |
| 2021-05-11 | European Network to Cure ALS Virtual Meeting |
| 2021-04-29 11:00 am | B. Riley Neurosciences Conference |
| 2021-04-28 04:15 am | Redeye Orphan Drugs Conference |
| 2021-03-31 | Guggenheim Healthcare Talks, Genomic Medicines & Rare Diseases Conference |
| 2021-03-25 12:00 pm | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 |
|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 0,00 0,00 - | 0,00 1,91 - |
|
EBITDA Million DKK | Released Forecast Spread | -332 -333 0.1% | -603 -541 -11.44% |
|
EBIT Million DKK | Released Forecast Spread | -336 -335 -0.28% | -609 -567 -7.27% |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | -343 -339 -1.33% | -635 -477 -33.13% |
|
Net income Million DKK | Released Forecast Spread | -337 -336 -0.45% | -633 -498 -27.12% |
|
EPS DKK | Released Forecast Spread | -16 870 -15 115 -11.61% | -22 320 -12 893 -73.12% |
| Announcement Date | 28/02/20 | 02/03/21 |
Quarterly results
| Fiscal Period | December | 2019 S2 | 2020 S2 | 2021 S1 |
|---|---|---|---|---|
|
Net sales Million DKK | Released Forecast Spread | 0,00 | 0,00 0,00 - | 13,2 0,00 - |
|
EBITDA Million DKK | Released Forecast Spread | -171 -333 48.58% | ||
|
EBIT Million DKK | Released Forecast Spread | -171 -335 48.99% | -363 -400 9.16% | |
|
Earnings before Tax (EBT) Million DKK | Released Forecast Spread | -382 -400 4.46% | ||
|
Net income Million DKK | Released Forecast Spread | -174 -338 48.64% | -382 -400 4.45% | |
|
EPS DKK | Released Forecast Spread | -8 660 0,00 - | ||
| Announcement Date | 28/02/20 | 02/03/21 | 31/08/21 |
More events
Past sector events for Orphazyme A/S
| 2024-04-17 | BEIJING KAWIN TECHNOLOGY SHARE-HOLDING CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 2024-04-17 | JIANGSU YAHONG MEDITECH CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-12 | SINOCELLTECH GROUP LIMITED: Q4 2023 Earnings Release |
| 2024-04-10 07:00 am | NURIX THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-04-08 | MABWELL (SHANGHAI) BIOSCIENCE CO., LTD.: Q4 2023 Earnings Release |
| 2024-04-02 03:06 am | TAIMED BIOLOGICS INC.: March 2024 Sales and Revenue Release |
| 2024-03-31 | PEPTRON, INC.: Q4 2023 Earnings Release (Projected) |
| 2024-03-31 | BIONEER CORPORATION: Q4 2023 Earnings Release (Projected) |
| 2024-03-29 08:30 am | INNOCARE PHARMA LIMITED: Q4 2023 Earnings Release |
| 2024-03-28 | BIO-THERA SOLUTIONS, LTD.: Q4 2023 Earnings Release |
- Stock Market
- Equities
- ORPHA Stock
- Calendar Orphazyme A/S
